Christopher D Byrne (Christopher Byrne)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 79

Top Topics

Cardiovascular Disease

Ejection Fraction

Top Venues

Diabetes, obesity & metabolism

Hepatology (Baltimore, Md.)

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Yoosun Cho, Yoosoo Chang, Seungho Ryu, Sarah H Wild, Christopher D Byrne
Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study. Diabetes, obesity & metabolism (2024)
Oluwakemi Lokulo-Sodipe, Hazel M Inskip, Christopher D Byrne, Jenny Child, Emma L Wakeling, Deborah J G Mackay, I Karen Temple, Justin Huw Davies
Body composition and metabolism in adults with molecularly-confirmed Silver-Russell syndrome. The Journal of clinical endocrinology and metabolism (2024)
Yoosun Cho, Yoosoo Chang, Seungho Ryu, Sarah H Wild, Christopher D Byrne
Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study. Diabetes, obesity & metabolism 26 (5) (2024)
Yoosoo Chang, Soon-Ho Yoon, Ria Kwon, Jeonggyu Kang, Young Hwan Kim, Jong-Min Kim, Han-Jae Chung, JunHyeok Choi, Hyun-Suk Jung, Ga-Young Lim, Jiin Ahn, Sarah D Wild, Christopher D Byrne, Seungho Ryu
Automated Comprehensive CT Assessment of the Risk of Diabetes and Associated Cardiometabolic Conditions. Radiology 312 (2) (2024)
Alessandro Mantovani, Fabiana Busti, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Elena Sani, Riccardo Morandin, Alessandro Csermely, Daniele Piasentin, Elisabetta Grespan, Annalisa Castagna, Josh Bilson, Christopher D Byrne, Luca Vittorio Valenti, Domenico Girelli, Giovanni Targher
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study. Cardiovascular diabetology 23 (1) (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut (2024)
Josh Bilson, Eleonora Scorletti, Jonathan R Swann, Christopher D Byrne
Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases. Biomolecules 14 (7) (2024)
Sungho Bea, Hwa Yeon Ko, Jae Hyun Bae, Young Min Cho, Yoosoo Chang, Seungho Ryu, Christopher D Byrne, Ju Young Shin
Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease. Gut (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association (2024)
Gong Feng, Na He, Jing Gao, Xiao-Cheng Li, Fen-Na Zhang, Cheng-Cheng Liu, Giovanni Targher, Christopher D Byrne, Man Mi, Ming-Hua Zheng, Feng Ye
Causal relationship between key genes and metabolic dysfunction-associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis. Diabetes, obesity & metabolism (2024)
Xiao-Dong Zhou, Cui-Fang Xu, Qin-Fen Chen, Michael D Shapiro, Gregory Yoke Hong Lip, Li-Li Chen, Giovanni Targher, Christopher D Byrne, Na Tian, Tie Xiao, Chen-Xiao Huang, Yan Ni, Ming-Hua Zheng
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study. Diabetes, obesity & metabolism 26 (9) (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut 73 (9) (2024)
Yoosoo Chang, Soon-Ho Yoon, Ria Kwon, Jeonggyu Kang, Young Hwan Kim, Jong-Min Kim, Han-Jae Chung, JunHyeok Choi, Hyun-Suk Jung, Ga-Young Lim, Jiin Ahn, Sarah D Wild, Christopher D Byrne, Seungho Ryu
Automated Comprehensive CT Assessment of the Risk of Diabetes and Associated Cardiometabolic Conditions. Radiology 312 (2) (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association 13 (3) (2024)
Alessandro Mantovani, Fabiana Busti, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Elena Sani, Riccardo Morandin, Alessandro Csermely, Daniele Piasentin, Elisabetta Grespan, Annalisa Castagna, Josh Bilson, Christopher D Byrne, Luca Vittorio Valenti, Domenico Girelli, Giovanni Targher
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study. Cardiovascular diabetology 23 (1) (2024)
Xiao-Dong Zhou, Seung-Up Kim, Terry Cheuk Fung Yip, Salvatore Petta, Atsushi Nakajima, Emmanuel Tsochatzis, Jérôme Boursier, Elisabetta Bugianesi, Hannes Hagström, Wah-Kheong Chan, Manuel Romero, Jose Luis Calleja, Victor de Lédinghen, Laurent Castéra, Arun J Sanyal, George Boon-Bee Goh, Philip Noel Newsome, Jiangao Fan, Michelle Lai, Céline Fournier-Poizat, Hye-Won Lee, Grace Lai-Hung Wong, Angelo Armandi, Ying Shang, Grazia Pennisi, Elba Llop, Masato Yoneda, Marc de Saint-Loup, Clémence M Canivet, Carmen Lara-Romero, Rocio Gallego-Duràn, Amon Asgharpour, Kevin Kim-Jun Teh, Sara Mahgoub, Mandy Sau-Wai Chan, Huapeng Lin, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Ming-Hua Zheng, null null
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease. Gut (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut 73 (9) (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association 13 (3) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association 13 (3) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Josh Bilson, Eleonora Scorletti, Jonathan R Swann, Christopher D Byrne
Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases. Biomolecules 14 (7) (2024)
Alessandro Mantovani, Fabiana Busti, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Elena Sani, Riccardo Morandin, Alessandro Csermely, Daniele Piasentin, Elisabetta Grespan, Annalisa Castagna, Josh Bilson, Christopher D Byrne, Luca Vittorio Valenti, Domenico Girelli, Giovanni Targher
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study. Cardiovascular diabetology 23 (1) (2024)
Yoosun Cho, Yoosoo Chang, Seungho Ryu, Sarah H Wild, Christopher D Byrne
Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study. Diabetes, obesity & metabolism 26 (5) (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association 13 (3) (2024)
Xiao-Dong Zhou, Cui-Fang Xu, Qin-Fen Chen, Michael D Shapiro, Gregory Yoke Hong Lip, Li-Li Chen, Giovanni Targher, Christopher D Byrne, Na Tian, Tie Xiao, Chen-Xiao Huang, Yan Ni, Ming-Hua Zheng
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study. Diabetes, obesity & metabolism (2024)
Josh Bilson, Eleonora Scorletti, Jonathan R Swann, Christopher D Byrne
Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases. Biomolecules 14 (7) (2024)
Hai-Yang Yuan, Wen-Yue Liu, Gong Feng, Sui-Dan Chen, Xin-Zhe Jin, Li-Li Chen, Zi-Jun Song, Ke Li, Christopher D Byrne, Giovanni Targher, Na Tian, Gang Li, Xin-Lei Zhang, Jacob George, Meng Zhou, Fudi Wang, Ming-Hua Zheng
Associations between cuprotosis-related genes and the spectrum of metabolic dysfunction-associated fatty liver disease: An exploratory study. Diabetes, obesity & metabolism (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Declan McDonnell, Paul R Afolabi, Sam Wilding, Gareth O Griffiths, Jonathan R Swann, Christopher D Byrne, Zaed Z R Hamady
Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma. Cancers 15 (24) (2023)
Andrew Collier, Christopher Curran, Lyall Cameron, Sarah D Wild, Christopher D Byrne
Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study). Diabetes, obesity & metabolism (2023)
Ki Chul Sung, Tae Kyung Yoo, Mi-Yeon Lee, Christopher D Byrne, Ming-Hua Zheng, Giovanni Targher
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2023)
Erica Jennison, Christopher D Byrne
Recent advances in NAFLD: current areas of contention. Faculty reviews 12 (2023)
Lena Tschiderer, Lisa Seekircher, Raffaele Izzo, Costantino Mancusi, Maria Virginia Manzi, Damiano Baldassarre, Mauro Amato, Elena Tremoli, Fabrizio Veglia, Tomi-Pekka Tuomainen, Jussi Kauhanen, Ari Voutilainen, Bernhard Iglseder, Lars Lind, Tatjana Rundek, Moise Desvarieux, Akihiko Kato, Eric de Groot, Gülay Aşçi, Ercan Ok, Stefan Agewall, Joline Wilhelma Johanna Beulens, Christopher D Byrne, Philip C Calder, Ulagamadesan Venkatesan, Paolo Gresele, Gerhard Klingenschmid, Michiaki Nagai, Michaels Hecht Olsen, Grace Parraga, Maya S Safarova, Naveed Sattar, Michael R Skilton, Coen D A Stehouwer, Heiko Uthoff, Michiel A van Agtmael, Amber A van der Heijden, Dorota A Zozulinska-Ziolkiewicz, Hyun-Woong Park, Moo-Sik Lee, Jang Ho Bae, Oscar Beloqui, Manuel F Landecho, Matthieu Plichart, Pierre Ducimetiere, Jean Philippe Empana, Lena Bokemark, Göran Bergstrom, Caroline Schmidt, Samuela Castelnuovo, Laura Calabresi, Giuseppe Danilo Norata, Liliana Grigore, Alberico Luigi Catapano, Dong Zhao, Miao Wang, Jing Liu, Mohammad Arfan Ikram, Maryam Kavousi, Michiel L Bots, Michael J Sweeting, Matthias W Lorenz, Peter Willeit, null null
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies. Journal of the American Heart Association (2023)
Ki Chul Sung, Tae Kyung Yoo, Mi-Yeon Lee, Christopher D Byrne, Ming-Hua Zheng, Giovanni Targher
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arteriosclerosis, thrombosis, and vascular biology (2023)
Erica Jennison, Christopher D Byrne
Recent advances in NAFLD: current areas of contention. Faculty reviews 12 (2023)
Nadeem Qureshi, Bethan Woods, Rita Isabel Neves de Faria, Pedro Saramago, Edward Cox, Jo Leonardi-Bee, Laura Condon, Stephen F Weng, Ralph Kwame Akyea, Barbara Iyen, Paul J Roderick, Steve E Humphries, William Rowlands, Melanie Watson, Kate Haralambos, Ryan P W Kenny, Dev Datta, Zofia Miedzybrodzka, Christopher D Byrne, Joe Kai
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health technology assessment (Winchester, England) 27 (16) (2023)
Declan McDonnell, Paul R Afolabi, Sam Wilding, Gareth O Griffiths, Jonathan R Swann, Christopher D Byrne, Zaed Z R Hamady
Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma. Cancers 15 (24) (2023)
Declan McDonnell, Paul R Afolabi, Sam Wilding, Gareth O Griffiths, Jonathan R Swann, Christopher D Byrne, Zaed Z R Hamady
Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma. Cancers 15 (24) (2023)
Ki Chul Sung, Tae Kyung Yoo, Mi-Yeon Lee, Christopher D Byrne, Ming-Hua Zheng, Giovanni Targher
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2023)
Declan McDonnell, Adrian W E Cheang, Sam Wilding, Sarah D Wild, Adam Enver Frampton, Christopher D Byrne, Zaed Z Hamady
Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study. Cancers 15 (16) (2023)
Ki Chul Sung, Tae Kyung Yoo, Mi-Yeon Lee, Christopher D Byrne, Ming-Hua Zheng, Giovanni Targher
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2023)
Christopher D Byrne, Giovanni Targher
Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people? Gut (2022)
Yoosun Cho, Yoosoo Chang, Seungho Ryu, Hyun-Suk Jung, Chan-Won Kim, Hyungseok Oh, Mi Kyung Kim, Won Sohn, Hocheol Shin, Sarah H Wild, Christopher D Byrne
Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex. Hepatology communications 6 (9) (2022)
Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, Giorgia Beatrice, Stefano Bonapace, Andrea Rossi, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals. Gut (2022)
Alessandro Mantovani, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals. Gut (2022)
Alessandro Mantovani, Antonio Taverna, Davide Cappelli, Giorgia Beatrice, Alessandro Csermely, Elena Sani, Christopher D Byrne, Giovanni Targher
Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. International journal of molecular sciences 23 (20) (2022)
In Young Choi, Yoosoo Chang, Yoosun Cho, Jeonggyu Kang, Hyun-Suk Jung, Sarah H Wild, Christopher D Byrne, Seungho Ryu
Prediabetes diagnosis is associated with the progression of coronary artery calcification: The Kangbuk Samsung Health Study. Diabetes, obesity & metabolism 24 (11) (2022)
Wenjing Xu, Changting Cui, Chunmei Cui, Zhenzhen Chen, Haizeng Zhang, Qinghua Cui, Guoheng Xu, Jianglin Fan, Yu Han, Liangjie Tang, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng, Liming Yang, Jun Cai, Bin Geng
Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor. Hepatology (Baltimore, Md.) 76 (6) (2022)
Yejin Kim, Jeonggyu Kang, Yoosoo Chang, Young Youl Hyun, Kyu-Beck Lee, Hocheol Shin, Sarah H Wild, Christopher D Byrne, Seungho Ryu
Coronary artery calcium and risk of chronic kidney disease in young and middle-aged adults. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Valentina Giampaoli, Alessandro Mantovani, Salvatore Petta, Amedeo Carraro, Christopher D Byrne, Giovanni Targher
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation. Nature reviews. Endocrinology 18 (10) (2022)
Christopher D Byrne
Banting memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime'. Diabetic medicine : a journal of the British Diabetic Association 39 (10) (2022)
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D Byrne, Dan-Qin Sun, Ming-Hua Zheng
Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nature reviews. Nephrology 18 (4) (2022)
Yejin Kim, Yoosoo Chang, Seungho Ryu, Sarah D Wild, Christopher D Byrne
NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status. Hepatology (Baltimore, Md.) 76 (6) (2022)
Liang-Jie Tang, Rafael S Rios, Huai Zhang, Christopher D Byrne, Giovanni Targher, Ming-Hua Zheng
Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease? Expert review of gastroenterology & hepatology 15 (7) (2021)
Hannes Hagström, Leon A Adams, Alina M Allen, Christopher D Byrne, Yoosoo Chang, Henning Grønbæk, Mona Ismail, Peter Jepsen, Fasiha Kanwal, Jennifer R Kramer, Jeffrey Victor Lazarus, Michelle T Long, Rohit Loomba, Philip Noel Newsome, Denis Moir, Seungho Ryu, Jörn Markus Schattenberg, Marina Serper, Nick Sheron, Tracey G Simon, Elliot B Tapper, Sarah Wild, Vincent Wai-Sun Wong, Yusuf Yilmaz, Shira Zelber-Sagi, Fredrik O Åberg
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement. Hepatology (Baltimore, Md.) 74 (1) (2021)
Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. Diabetes, obesity & metabolism (2021)
Josh Bilson, Eleonora Scorletti, Laure B Bindels, Paul R Afolabi, Giovanni Targher, Philip C Calder, Jaswinder K Sethi, Christopher D Byrne
Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD. Nutrition & diabetes 11 (1) (2021)
Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed. Gut (2021)
Giovanni Targher, Kathleen E Corey, Christopher D Byrne, Michael Roden
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nature reviews. Gastroenterology & hepatology 18 (9) (2021)
Paul Remi Afolabi, Eleonora Scorletti, Philip C Calder, Christopher D Byrne
Factors independently associated with cardiorespiratory fitness in patients with non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 40 (12) (2020)
Sven M Francque, Gyongyi Szabo, Manal F Abdelmalek, Christopher D Byrne, Kenneth Cusi, Jean-François Dufour, Michael Roden, Frank Sacks, Frank Tacke
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. Nature reviews. Gastroenterology & hepatology 18 (1) (2020)
Yusuf Yilmaz, Christopher D Byrne, Giovanni Musso
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert review of gastroenterology & hepatology 15 (4) (2020)
Christopher D Byrne, Giovanni Targher
What's new in NAFLD pathogenesis, biomarkers and treatment? Nature reviews. Gastroenterology & hepatology 17 (2) (2020)
Ki Chul Sung, Michael P Johnston, Mi-Yeon Lee, Christopher D Byrne
Non-invasive liver fibrosis scores are strongly associated with liver cancer mortality in general population without liver disease. Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69 (9) (2020)
Feng-Bin Lu, Kenneth I Zheng, Rafael S Rios, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of gastroenterology and hepatology 35 (12) (2020)
Kenneth I Zheng, Gong Feng, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Extrapulmonary complications of COVID-19: A multisystem disease? Journal of medical virology 93 (1) (2020)
Antonella Mosca, Donatella Comparcola, Ilaria Romito, Alessandro Mantovani, Valerio Nobili, Christopher D Byrne, Anna Alisi, Giovanni Targher
Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 39 (12) (2019)
Andrew J Chipperfield, Marjola Thanaj, Eleonora Scorletti, Christopher D Byrne, Geraldine F Clough
Multi-domain analysis of microvascular flow motion dynamics in NAFLD. Microcirculation (New York, N.Y. : 1994) 26 (5) (2019)
Alessandro Mantovani, Davide Gatti, Giacomo Zoppini, Giuseppe Lippi, Enzo Bonora, Christopher D Byrne, Valerio Nobili, Giovanni Targher
Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis. Hepatology (Baltimore, Md.) 70 (3) (2019)
Erica Jennison, Janisha Patel, Eleonora Scorletti, Christopher D Byrne
Diagnosis and management of non-alcoholic fatty liver disease. Postgraduate medical journal 95 (1124) (2019)
Yoosoo Chang, Seungho Ryu, Yejin Kim, Yong Kyun Cho, Eunju Sung, Han-Na Kim, Jiin Ahn, Hyun-Suk Jung, Kyung Eun Yun, Seolhye Kim, Ki-Chul Sung, Chong Il Sohn, Hocheol Shin, Sarah H Wild, Christopher D Byrne
Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis. Hepatology (Baltimore, Md.) 71 (3) (2019)
Giovanni Targher, Alessandro Mantovani, Anna Alisi, Antonella Mosca, Nadia Panera, Christopher D Byrne, Valerio Nobili
Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. Hepatology (Baltimore, Md.) 70 (1) (2019)
Alison Rowsell, Ingrid Muller, Elizabeth Murray, Paul Little, Christopher D Byrne, Kristin Ganahl, Gabriele Müller, Sarah Gibney, Courtney Rees Lyles, Antonia Lucas, Don Nutbeam, Lucy Yardley
Views of People With High and Low Levels of Health Literacy About a Digital Intervention to Promote Physical Activity for Diabetes: A Qualitative Study in Five Countries. Journal of medical Internet research 17 (10) (2015)